|Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling|
AA Alizadeh, MB Eisen, RE Davis, C Ma, IS Lossos, A Rosenwald, ...
Nature 403 (6769), 503-511, 2000
|Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.|
P McLaughlin, AJ Grillo-López, BK Link, R Levy, MS Czuczman, ...
Journal of clinical oncology 16 (8), 2825-2833, 1998
|Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma|
SS Neelapu, FL Locke, NL Bartlett, LJ Lekakis, DB Miklos, CA Jacobson, ...
New England Journal of Medicine 377 (26), 2531-2544, 2017
|Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells|
FJ Hsu, C Benike, F Fagnoni, TM Liles, D Czerwinski, B Taidi, ...
Nature medicine 2 (1), 52-58, 1996
|IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma|
DG Maloney, AJ Grillo-López, CA White, D Bodkin, RJ Schilder, ...
Blood, The Journal of the American Society of Hematology 90 (6), 2188-2195, 1997
|Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma|
WK Weng, R Levy
Journal of clinical oncology 21 (21), 3940-3947, 2003
|The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy|
LA Honigberg, AM Smith, M Sirisawad, E Verner, D Loury, B Chang, S Li, ...
Proceedings of the National Academy of Sciences 107 (29), 13075-13080, 2010
|Two populations of Ia-like molecules on a human B cell line.|
LA Lampson, R Levy
The Journal of Immunology 125 (1), 293-299, 1980
|Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody|
RA Miller, DG Maloney, R Warnke, R Levy
New England Journal of Medicine 306 (9), 517-522, 1982
|Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial|
E Abraham, R Wunderink, H Silverman, TM Perl, S Nasraway, H Levy, ...
Jama 273 (12), 934-941, 1995
|Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes|
IS Lossos, DK Czerwinski, AA Alizadeh, MA Wechser, R Tibshirani, ...
New England Journal of Medicine 350 (18), 1828-1837, 2004
|Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma|
MP Chao, AA Alizadeh, C Tang, JH Myklebust, B Varghese, S Gill, M Jan, ...
Cell 142 (5), 699-713, 2010
|Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia|
JW Friedberg, J Sharman, J Sweetenham, PB Johnston, JM Vose, ...
Blood, The Journal of the American Society of Hematology 115 (13), 2578-2585, 2010
|Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin’s lymphoma: safety and efficacy of re-treatment|
TA Davis, AJ Grillo-López, CA White, P McLaughlin, MS Czuczman, ...
Journal of clinical oncology 18 (17), 3135-3143, 2000
|IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.|
DG Maloney, AJ Grillo-López, DJ Bodkin, CA White, TM Liles, I Royston, ...
Journal of clinical oncology 15 (10), 3266-3274, 1997
|Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients|
JM Timmerman, DK Czerwinski, TA Davis, FJ Hsu, C Benike, ZM Hao, ...
Blood, The Journal of the American Society of Hematology 99 (5), 1517-1526, 2002
|'Gene shaving'as a method for identifying distinct sets of genes with similar expression patterns|
T Hastie, R Tibshirani, MB Eisen, A Alizadeh, R Levy, L Staudt, WC Chan, ...
Genome biology 1 (2), 1-21, 2000
|Dendritic cell vaccines for cancer immunotherapy|
JM Timmerman, R Levy
Annual review of medicine 50, 1999
|Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors|
LW Kwak, MJ Campbell, DK Czerwinski, S Hart, RA Miller, R Levy
New England Journal of Medicine 327 (17), 1209-1215, 1992
|Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma—long-term results of a clinical trial|
FJ Hsu, CB Caspar, D Czerwinski, LW Kwak, TM Liles, A Syrengelas, ...
Blood, The Journal of the American Society of Hematology 89 (9), 3129-3135, 1997